Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder
Clinical trial NCT01868516 · COMPLETED
Trial details
- NCT number
- NCT01868516
- Sponsor
- Targacept Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-06-01
- Enrollment
- 1635
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.